A potential systematic error in using lysivane as inhibitor in the measurement of amniotic fluid acetylcholinesterase by the Ellman method.
The measurement of low levels of cholinesterase or acetylcholinesterase by the Ellman method requires correction for a non-enzymatic increase in absorption at 412 millimicron that is due both to non-enzymatic hydrolysis of the acetylthiocholine substrate and to modification of the colour reagent. The rate of increase in absorption is dependent on temperature and pH. Addition of an acidic solution of lysivane to the assay solution for selective measurement of amniotic fluid acetylcholinesterase gives rise to a shift in pH; the use of methanol is suggested as an easier method of dissolving the inhibitor and does not affect the pH of the assay, obviating any need to redetermine the background absorption. There is, however, no improvement in ability of the method to predict pregnancies associated with neural-tube defects.
D000110:Acetylcholinesterase / Q000032:analysis*; D000122:Acetylthiocholine; D000653:Amniotic Fluid / Q000201:enzymology*; D002800:Cholinesterase Inhibitors; D003951:Diagnostic Errors; D004228:Dithionitrobenzoic Acid; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008832:Microchemistry; D010640:Phenothiazines; D011247:Pregnancy
D002800:Cholinesterase Inhibitors; D010640:Phenothiazines; D000122:Acetylthiocholine; D004228:Dithionitrobenzoic Acid; D000110:Acetylcholinesterase